These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22015471)

  • 1. Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
    Pocernich CB; Butterfield DA
    Biochim Biophys Acta; 2012 May; 1822(5):625-30. PubMed ID: 22015471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional approaches to modulate oxidative stress in Alzheimer's disease.
    Pocernich CB; Lange ML; Sultana R; Butterfield DA
    Curr Alzheimer Res; 2011 Aug; 8(5):452-69. PubMed ID: 21605052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of nitrated brain proteins in traumatic brain-injured rats treated postinjury with gamma-glutamylcysteine ethyl ester: insights into the role of elevation of glutathione as a potential therapeutic strategy for traumatic brain injury.
    Reed TT; Owen J; Pierce WM; Sebastian A; Sullivan PG; Butterfield DA
    J Neurosci Res; 2009 Feb; 87(2):408-17. PubMed ID: 18803298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Boyd-Kimball D; Sultana R; Abdul HM; Butterfield DA
    J Neurosci Res; 2005 Mar; 79(5):700-6. PubMed ID: 15678514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
    Huang Q; Aluise CD; Joshi G; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
    J Neurosci Res; 2010 Sep; 88(12):2618-29. PubMed ID: 20648652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress.
    Drake J; Kanski J; Varadarajan S; Tsoras M; Butterfield DA
    J Neurosci Res; 2002 Jun; 68(6):776-84. PubMed ID: 12111838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain.
    Joshi G; Hardas S; Sultana R; St Clair DK; Vore M; Butterfield DA
    J Neurosci Res; 2007 Feb; 85(3):497-503. PubMed ID: 17171703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress.
    Drake J; Sultana R; Aksenova M; Calabrese V; Butterfield DA
    J Neurosci Res; 2003 Dec; 74(6):917-27. PubMed ID: 14648597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE).
    Aluise CD; St Clair D; Vore M; Butterfield DA
    Cancer Lett; 2009 Sep; 282(1):25-9. PubMed ID: 19342159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.
    Mecocci P; Polidori MC
    Biochim Biophys Acta; 2012 May; 1822(5):631-8. PubMed ID: 22019723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Martínez de Toda I; Miguélez L; Vida C; Carro E; De la Fuente M
    J Alzheimers Dis; 2019; 71(1):153-163. PubMed ID: 31356205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-Glutamylcysteine Ethyl Ester Protects against Cyclophosphamide-Induced Liver Injury and Hematologic Alterations via Upregulation of PPAR
    Alqahtani S; Mahmoud AM
    Oxid Med Cell Longev; 2016; 2016():4016209. PubMed ID: 28074115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
    Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
    Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis.
    Hamzeh N; Li L; Barkes B; Huang J; Canono B; Gillespie M; Maier L; Day B
    Respir Med; 2016 Mar; 112():106-11. PubMed ID: 26831541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements.
    Tadokoro K; Ohta Y; Inufusa H; Loon AFN; Abe K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
    Coles LD; Tuite PJ; Öz G; Mishra UR; Kartha RV; Sullivan KM; Cloyd JC; Terpstra M
    J Clin Pharmacol; 2018 Feb; 58(2):158-167. PubMed ID: 28940353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2008 Sep; 15(1):117-28. PubMed ID: 18780972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.